Status:
COMPLETED
A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy
Lead Sponsor:
UCB Pharma
Collaborating Sponsors:
SCHWARZ BIOSCIENCES GmbH - Part of UCB Group
Conditions:
Painful Diabetic Neuropathy
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine if lacosamide (SPM 927) is safe if taken for a longer period of time and whether it continues to work well to treat pain. Subjects will receive lacosamide at...
Eligibility Criteria
Inclusion
- Painful diabetic neuropathy
Exclusion
- no clinically relevant liver enzyme abnormalities and impaired renal function, no cardiac abnormalities, no pregnant or nursing females
Key Trial Info
Start Date :
December 21 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2007
Estimated Enrollment :
371 Patients enrolled
Trial Details
Trial ID
NCT00220337
Start Date
December 21 2004
End Date
October 31 2007
Last Update
July 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Monheim, Germany